(Total Views: 567)
Posted On: 09/25/2025 7:23:08 AM
Post# of 157267
https://www.cytodyn.com/newsroom/detail/645/c...conference
A reminder that Dr. Pestell makes the poster presentation tomorrow and his podium presentation on Saturday.
Abstract Title:
CCR5 inhibition with leronlimab is associated with enhanced PD-L1 expression, ICI response, and long‑term survival in metastatic TNBC
A reminder that Dr. Pestell makes the poster presentation tomorrow and his podium presentation on Saturday.
Abstract Title:
CCR5 inhibition with leronlimab is associated with enhanced PD-L1 expression, ICI response, and long‑term survival in metastatic TNBC
(11)
(0)
